CAS No.: 2108449-45-0
4-((9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide hydrochloride Catalog No. CSN17496
TAK-960 HCl is an investigational, orally bioavailable, potent, and selective PLK1 inhibitor (IC50=1.5 nM) that has shown activity in several tumor cell lines, including those that express multidrug-resistant protein 1 (MDR1).
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 2108449-45-0 | 储存条件 |
|
|
| 分子式 | C27H35ClF3N7O3 | 运输 | 蓝冰 | |
| 分子量 | 598.06 | 别名 |
